IridescentBio

IridescentBio provides an AI-ready platform offering rigorous predictive analytics for antibody development. By leveraging deep data and computational science, the platform runs high-throughput virtual assays to predict factors like aggregation risks and IP strength early in the development cycle. This allows biotech companies to de-risk candidates, select stronger antibodies (Abs), and potentially bring blockbuster antibody therapeutics to market faster.